TY - JOUR
T1 - Obsessive-compulsive disorder
AU - Drubach, Daniel A.
N1 - Publisher Copyright:
© 2015 by the American Academy of Neurology.
PY - 2015/6/5
Y1 - 2015/6/5
N2 - This article discusses the neurobiology, clinical features, and treatment of obsessive-compulsive disorder (OCD), as well as its association with psychiatric and neurologic disease. Recent Findings: OCD can be associated with various neurologic disorders. Recent studies have better elucidated the neurobiology of OCD, and this new knowledge promises to have a significant impact on future treatments. Summary: OCD is a syndrome characterized by obsessions and compulsions, as well as other neuropsychiatric features, and is often associated with primary psychiatric disorders and various neurologic conditions. If severe, OCD can seriously interfere with the patient's quality of life. The mainstay of treatment is psychotherapy, especially cognitive-behavioral therapy, and pharmacologic interventions, especially with selective serotonin reuptake inhibitors (SSRIs). Unfortunately, a significant proportion of patients are refractory to these treatment modalities. New understanding about the neurobiology of OCD has led to novel investigational treatments, especially neuromodulation techniques.
AB - This article discusses the neurobiology, clinical features, and treatment of obsessive-compulsive disorder (OCD), as well as its association with psychiatric and neurologic disease. Recent Findings: OCD can be associated with various neurologic disorders. Recent studies have better elucidated the neurobiology of OCD, and this new knowledge promises to have a significant impact on future treatments. Summary: OCD is a syndrome characterized by obsessions and compulsions, as well as other neuropsychiatric features, and is often associated with primary psychiatric disorders and various neurologic conditions. If severe, OCD can seriously interfere with the patient's quality of life. The mainstay of treatment is psychotherapy, especially cognitive-behavioral therapy, and pharmacologic interventions, especially with selective serotonin reuptake inhibitors (SSRIs). Unfortunately, a significant proportion of patients are refractory to these treatment modalities. New understanding about the neurobiology of OCD has led to novel investigational treatments, especially neuromodulation techniques.
UR - http://www.scopus.com/inward/record.url?scp=84930461784&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84930461784&partnerID=8YFLogxK
U2 - 10.1212/01.CON.0000466666.12779.07
DO - 10.1212/01.CON.0000466666.12779.07
M3 - Review article
C2 - 26039854
AN - SCOPUS:84930461784
SN - 1080-2371
VL - 21
SP - 783
EP - 788
JO - Continuum (Minneapolis, Minn.)
JF - Continuum (Minneapolis, Minn.)
IS - 3
ER -